Warning: This security is no longer trading.
defunct
Concordia International Corp. (CXRX): Price and Financial Metrics
CXRX Price/Volume Stats
| Current price | $0.19 | 52-week high | $1.80 |
| Prev. close | $0.19 | 52-week low | $0.19 |
| Day low | $0.19 | Volume | 648,800 |
| Day high | $0.20 | Avg. volume | 191,656 |
| 50-day MA | $0.38 | Dividend yield | N/A |
| 200-day MA | $0.68 | Market Cap | 9.74M |
CXRX Stock Price Chart Interactive Chart >
Concordia International Corp. (CXRX) Company Bio
Concordia International operates as an integrated healthcare company that focuses on legacy pharmaceutical products and orphan drugs for the diabetic market. The company operates through three divisions: Legacy Pharmaceuticals, Specialty Healthcare Distribution, and Orphan Drugs. The company was founded in 2012 and is based in Oakville, Canada.
CXRX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...